Why the study?
Does ramipril reduce death, myocardial infarction, and stroke in high-risk patients without low ejection fraction or heart failure?
Does ramipril reduce death, myocardial infarction, and stroke in high-risk patients without low ejection fraction or heart failure?
Ramipril significantly reduces death, myocardial infarction, and stroke in high-risk patients without heart failure or low ejection fraction.
Answers are grounded in this paper and cite their sources.
Supports ramipril in high-risk patients without HF or low EF; extends ACEI benefits beyond systolic dysfunction.
Ramipril significantly reduces the rates of death, myocardial infarction, and stroke in a broad range of high-risk patients who are not known to have a low ejection fraction or heart failure.
No takes yet. Share an insight, caveat, or question.
Salim Yusuf (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: